Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Price, Quote, News and Overview

NASDAQ:BBH - Nasdaq - US92189F7261 - ETF - Currency: USD

152.47  +1.29 (+0.85%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BBH. BBH was compared to 81 industry peers in the Automobile Components industry. BBH has only an average score on both its financial health and profitability. BBH is valied quite expensively at the moment, while it does show a decent growth rate. BBH also has an excellent dividend rating. These ratings would make BBH suitable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

BBH had positive earnings in the past year.
BBH had a positive operating cash flow in the past year.
In the past 5 years BBH has always been profitable.
Each year in the past 5 years BBH had a positive operating cash flow.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.04%, BBH is in line with its industry, outperforming 44.44% of the companies in the same industry.
BBH has a Return On Equity of 10.12%. This is comparable to the rest of the industry: BBH outperforms 43.21% of its industry peers.
With a Return On Invested Capital value of 8.73%, BBH perfoms like the industry average, outperforming 43.21% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BBH is in line with the industry average of 9.04%.
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROIC 8.73%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BBH has a Profit Margin of 6.93%. This is comparable to the rest of the industry: BBH outperforms 46.91% of its industry peers.
In the last couple of years the Profit Margin of BBH has remained more or less at the same level.
The Operating Margin of BBH (11.72%) is comparable to the rest of the industry.
BBH's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 28.49%, BBH perfoms like the industry average, outperforming 41.98% of the companies in the same industry.
BBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

BBH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BBH has less shares outstanding
BBH has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BBH is higher compared to a year ago.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

BBH has an Altman-Z score of 4.83. This indicates that BBH is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.83, BBH belongs to the best of the industry, outperforming 86.42% of the companies in the same industry.
BBH has a debt to FCF ratio of 3.42. This is a good value and a sign of high solvency as BBH would need 3.42 years to pay back of all of its debts.
With a Debt to FCF ratio value of 3.42, BBH perfoms like the industry average, outperforming 46.91% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that BBH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, BBH is doing worse than 60.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.42
Altman-Z 4.83
ROIC/WACC1.15
WACC7.59%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.76 indicates that BBH should not have too much problems paying its short term obligations.
BBH has a worse Current ratio (1.76) than 75.31% of its industry peers.
BBH has a Quick Ratio of 1.11. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BBH (1.11) is worse than 75.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.11
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

4

3. Growth

3.1 Past

BBH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.42%.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
Looking at the last year, BBH shows a decrease in Revenue. The Revenue has decreased by -4.06% in the last year.
BBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%

3.2 Future

BBH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.51% yearly.
BBH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.22% yearly.
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue Next Year0.83%
Revenue Next 2Y2%
Revenue Next 3Y2.43%
Revenue Next 5Y3.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 51.16, the valuation of BBH can be described as expensive.
76.54% of the companies in the same industry are cheaper than BBH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BBH to the average of the S&P500 Index (26.43), we can say BBH is valued expensively.
BBH is valuated quite expensively with a Price/Forward Earnings ratio of 37.77.
Based on the Price/Forward Earnings ratio, BBH is valued a bit more expensive than the industry average as 79.01% of the companies are valued more cheaply.
BBH is valuated expensively when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 51.16
Fwd PE 37.77
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BBH is valued a bit more expensive than 79.01% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BBH is valued a bit more expensive than the industry average as 76.54% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 43.88
EV/EBITDA 18.58
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BBH's earnings are expected to grow with 17.51% in the coming years.
PEG (NY)1.45
PEG (5Y)31.14
EPS Next 2Y23.07%
EPS Next 3Y17.51%

More info and screens

8

5. Dividend

5.1 Amount

BBH has a Yearly Dividend Yield of 4.07%, which is a nice return.
Compared to an average industry Dividend Yield of 4.14, BBH pays a better dividend. On top of this BBH pays more dividend than 92.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, BBH pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.07%

5.2 History

The dividend of BBH is nicely growing with an annual growth rate of 7.84%!
BBH has been paying a dividend for at least 10 years, so it has a reliable track record.
BBH has decreased its dividend recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BBH pays out 51.01% of its income as dividend. This is a bit on the high side, but may be sustainable.
BBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.01%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK BIOTECH ETF

NASDAQ:BBH (6/5/2025, 11:58:53 AM)

152.47

+1.29 (+0.85%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-24 2025-07-24
Inst Owners39.74%
Inst Owner Change0.04%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap107.61B
Analysts77.6
Price Target172.67 (13.25%)
Short Float %0%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield 4.07%
Yearly Dividend1.53
Dividend Growth(5Y)7.84%
DP51.01%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.18%
PT rev (3m)-6.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 51.16
Fwd PE 37.77
P/S 3.48
P/FCF 43.88
P/OCF 21.8
P/B 5.08
P/tB 6.91
EV/EBITDA 18.58
EPS(TTM)2.98
EY1.95%
EPS(NY)4.04
Fwd EY2.65%
FCF(TTM)3.47
FCFY2.28%
OCF(TTM)6.99
OCFY4.59%
SpS43.86
BVpS30.04
TBVpS22.06
PEG (NY)1.45
PEG (5Y)31.14
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROCE 11.13%
ROIC 8.73%
ROICexc 10.35%
ROICexgc 13.02%
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
FCFM 7.92%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.42
Debt/EBITDA 1.12
Cap/Depr 110.04%
Cap/Sales 8.02%
Interest Coverage 12.7
Cash Conversion 83.87%
Profit Quality 114.33%
Current Ratio 1.76
Quick Ratio 1.11
Altman-Z 4.83
F-Score5
WACC7.59%
ROIC/WACC1.15
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%
Revenue Next Year0.83%
Revenue Next 2Y2%
Revenue Next 3Y2.43%
Revenue Next 5Y3.22%
EBIT growth 1Y-7.52%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.57%
FCF growth 1Y-29.4%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-17.99%
OCF growth 3Y14.27%
OCF growth 5Y5.48%